Zeitschriftenartikel zum Thema „DLT alternatives de consortium“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "DLT alternatives de consortium" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Monje, Michelle, Tabitha Cooney, John Glod, Jie Huang, Patricia Baxter, Anna Vinitsky, Lindsay Kilburn et al. „DIPG-10. A Phase I trial of panobinostat following radiation therapy in children with diffuse intrinsic pontine glioma (DIPG) or H3K27M-mutated thalamic diffuse midline glioma (DMG): Report from the Pediatric Brain Tumor Consortium (PBTC-047)“. Neuro-Oncology 24, Supplement_1 (01.06.2022): i19—i20. http://dx.doi.org/10.1093/neuonc/noac079.067.
Der volle Inhalt der QuelleShah, Nirali N., Sarah K. Tasian, M. Eric Kohler, Emily M. Hsieh, Susanne H. C. Baumeister, Corinne Summers, Haneen Shalabi et al. „CD33 CAR T-Cells (CD33CART) for Children and Young Adults with Relapsed/Refractory AML: Dose-Escalation Results from a Phase I/II Multicenter Trial“. Blood 142, Supplement 1 (28.11.2023): 771. http://dx.doi.org/10.1182/blood-2023-179667.
Der volle Inhalt der QuelleEbben, John, Jens C. Eickhoff, Dustin A. Deming, Howard S. Hochster, Anita Ahmed Turk, Vaibhav Sahai und Nataliya Volodymyrivna Uboha. „QUIC: Phase 2 study of gemcitabine, cisplatin, quemliclustat (AB680), and zimberelimab (AB122) during first-line treatment of advanced biliary tract cancers (BTC)—Big Ten Cancer Research Consortium study BTCRC-GI22-564.“ Journal of Clinical Oncology 42, Nr. 16_suppl (01.06.2024): TPS4195. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.tps4195.
Der volle Inhalt der QuelleIslam, Md Rafiqul, Muhammad Mahbubur Rahman, Mohammed Ataur Rahman, Muslin Har Sani Mohamad und Abd Halim Embang. „A Review on Blockchain Technology for Distribution of Energy“. International Journal of Engineering Materials and Manufacture 7, Nr. 2 (22.04.2022): 61–70. http://dx.doi.org/10.26776/ijemm.07.02.2022.03.
Der volle Inhalt der QuellePoh, Christina, Paul Frankel, Christopher Ruel, Mehrdad Abedi, Emily Schwab, Caitlin L. Costello, Jasmine Zain et al. „Blinatumomab/Lenalidomide in Relapsed/Refractory Non-Hodgkin's Lymphoma: A Phase I California Cancer Consortium Study of Safety, Efficacy and Immune Correlative Analysis“. Blood 134, Supplement_1 (13.11.2019): 760. http://dx.doi.org/10.1182/blood-2019-124254.
Der volle Inhalt der QuellePhadke, Sneha, Kari Wisinski, Oana Danciu, Ami Shah, Menggang Yu, Yi Chen, Kathy Miller und Mark Burkard. „Abstract PO1-06-09: Phase 2 Trial with Safety Run-In of Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast CancersBig Ten Cancer Research Consortium BTCRC-BRE18-337“. Cancer Research 84, Nr. 9_Supplement (02.05.2024): PO1–06–09—PO1–06–09. http://dx.doi.org/10.1158/1538-7445.sabcs23-po1-06-09.
Der volle Inhalt der QuelleWen, P. Y., T. Cloughesy, J. Kuhn, K. Lamborn, L. E. Abrey, F. Lieberman, H. I. Robins, J. Wright, M. D. Prados und M. Gilbert. „Phase I/II study of sorafenib and temsirolimus for patients with recurrent glioblastoma (GBM) (NABTC 05–02)“. Journal of Clinical Oncology 27, Nr. 15_suppl (20.05.2009): 2006. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.2006.
Der volle Inhalt der QuelleMinard, Charles Gene, Rachel Rau, Susan Hilsenbeck, Brenda J. Weigel, Elizabeth Fox, Peter Adamson und Susan Blaney. „3488 A comparison between the Rolling 6 and 3+3 dose escalation study designs for phase 1 clinical trials“. Journal of Clinical and Translational Science 3, s1 (März 2019): 30–31. http://dx.doi.org/10.1017/cts.2019.73.
Der volle Inhalt der QuelleGuo, Dong, und Peng Zhou. „The Evolution of Financial Market Infrastructure: From Digitalization to Tokenization“. International Journal of Innovation and Entrepreneurship 2, Nr. 1 (08.03.2023): 1. http://dx.doi.org/10.56502/ijie2010002.
Der volle Inhalt der QuelleMthethwa, Sthembile, und Morne Pretorius. „Academic and Skills Credentialing Using Distributed Ledger Technology (DLT) and W3C Standards: Technology Assessment“. International Conference on Intelligent and Innovative Computing Applications 2022 (31.12.2022): 170–82. http://dx.doi.org/10.59200/iconic.2022.019.
Der volle Inhalt der QuelleGerring, John, und Daniel Pemstein. „Proposal: A Political Science Peer Review and Publication Consortium“. PS: Political Science & Politics 54, Nr. 1 (28.10.2020): 126–30. http://dx.doi.org/10.1017/s104909652000102x.
Der volle Inhalt der QuelleAntal, Claudia, Tudor Cioara, Ionut Anghel, Marcel Antal und Ioan Salomie. „Distributed Ledger Technology Review and Decentralized Applications Development Guidelines“. Future Internet 13, Nr. 3 (27.02.2021): 62. http://dx.doi.org/10.3390/fi13030062.
Der volle Inhalt der QuelleMohrbacher, Ann, Min H. Kang, Allen S. Yang, Susan G. Groshen, Lori Vergara, Martin Gutierrez, Anthony J. Murgo et al. „Phase I trial of fenretinide (4-HPR) intravenous emulsion in hematologic malignancies: A California Cancer Consortium study (PhI-42).“ Journal of Clinical Oncology 30, Nr. 15_suppl (20.05.2012): 8073. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.8073.
Der volle Inhalt der QuelleBerg, S. L., H. Russell, M. Cairo, A. M. Ingle, P. C. Adamson und S. M. Blaney. „Phase I and pharmacokinetic (PK) study of lenalidomide (LEN) in pediatric patients with relapsed/refractory solid tumors or myelodysplastic syndrome (MDS): A Children's Oncology Group Phase I Consortium study“. Journal of Clinical Oncology 27, Nr. 15_suppl (20.05.2009): 10023. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.10023.
Der volle Inhalt der QuelleBurke, Michael J., Patrick Brown, Richard Sposto, Lia Gore und Alan S. Wayne. „Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL: A Report from the Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium“. Blood 128, Nr. 22 (02.12.2016): 2781. http://dx.doi.org/10.1182/blood.v128.22.2781.2781.
Der volle Inhalt der QuelleKleinberg, Lawrence, Jeffrey G. Supko, Tom Mikkelsen, Jaishri O'Neill Blakeley, Glen Stevens, Xiaobu Ye, Serena Desideri et al. „Phase I adult brain tumor consortium (ABTC) trial of ABT-888 (veliparib), temozolomide (TMZ), and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM) including pharmacokinetic (PK) data.“ Journal of Clinical Oncology 31, Nr. 15_suppl (20.05.2013): 2065. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.2065.
Der volle Inhalt der QuelleCombi, Romina, Maria Salsone, Chiara Villa und Luigi Ferini-Strambi. „Genetic Architecture and Molecular, Imaging and Prodromic Markers in Dementia with Lewy Bodies: State of the Art, Opportunities and Challenges“. International Journal of Molecular Sciences 22, Nr. 8 (12.04.2021): 3960. http://dx.doi.org/10.3390/ijms22083960.
Der volle Inhalt der QuelleAplenc, Richard, Susan M. Blaney, Lewis C. Strauss, Frank M. Balis, Suzanne Shusterman, Ashish Mark Ingle, Shruti Agrawal, Junfeng Sun, John J. Wright und Peter C. Adamson. „Pediatric Phase I Trial and Pharmacokinetic Study of Dasatinib: A Report From the Children's Oncology Group Phase I Consortium“. Journal of Clinical Oncology 29, Nr. 7 (01.03.2011): 839–44. http://dx.doi.org/10.1200/jco.2010.30.7231.
Der volle Inhalt der QuelleOlanrewaju, Oluwaseyi Samuel, und Olubukola Oluranti Babalola. „Bacterial Consortium for Improved Maize (Zea mays L.) Production“. Microorganisms 7, Nr. 11 (01.11.2019): 519. http://dx.doi.org/10.3390/microorganisms7110519.
Der volle Inhalt der QuelleLeichman, Lawrence P., Bert H. O'Neil, Jordan Berlin, Colin D. Weekes, Patricia Ames, Marti McKinley, Angela M. Davies und Steven J. Cohen. „A phase IB study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: An Academic GI Cancer Consortium (AGICC) study.“ Journal of Clinical Oncology 30, Nr. 15_suppl (20.05.2012): 4052. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.4052.
Der volle Inhalt der QuelleHinrichs, Richard N., und Scott P. McLean. „NLT and extrapolated DLT: 3-D cinematography alternatives for enlarging the volume of calibration“. Journal of Biomechanics 28, Nr. 10 (Oktober 1995): 1219–23. http://dx.doi.org/10.1016/0021-9290(95)00034-f.
Der volle Inhalt der QuelleSomlo, George, Joseph A. Sparano, Tessa Cigler, Gini F. Fleming, Thehang H. Luu, Arti Hurria, Joanne E. Mortimer et al. „ABT-888 (veliparib) in combination with carboplatin in patients with stage IV BRCA-associated breast cancer. A California Cancer Consortium Trial.“ Journal of Clinical Oncology 30, Nr. 15_suppl (20.05.2012): 1010. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1010.
Der volle Inhalt der QuelleLedwaba, Lehlogonolo P. I., Gerhard P. Hancke, Sherrin J. Isaac und Hein S. Venter. „Smart Microgrid Energy Market: Evaluating Distributed Ledger Technologies for Remote and Constrained Microgrid Deployments“. Electronics 10, Nr. 6 (18.03.2021): 714. http://dx.doi.org/10.3390/electronics10060714.
Der volle Inhalt der QuelleWagner, L. M., J. P. Perentesis, J. M. Reid, M. M. Ames, S. L. Safgren, M. D. Nelson, A. M. Ingle, S. M. Blaney und P. C. Adamson. „Phase I trial and pharmacokinetic study of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with refractory solid tumors: A Children's Oncology Group Phase I Consortium study“. Journal of Clinical Oncology 27, Nr. 15_suppl (20.05.2009): 10017. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.10017.
Der volle Inhalt der QuelleDelgado, Ninoska, Matías Olivera, Fabiola Cádiz, Guillermo Bravo, Iván Montenegro, Alejandro Madrid, Claudia Fuentealba, Romina Pedreschi, Eduardo Salgado und Ximena Besoain. „Volatile Organic Compounds (VOCs) Produced by Gluconobacter cerinus and Hanseniaspora osmophila Displaying Control Effect against Table Grape-Rot Pathogens“. Antibiotics 10, Nr. 6 (01.06.2021): 663. http://dx.doi.org/10.3390/antibiotics10060663.
Der volle Inhalt der QuelleGoldsmith, Kelly C., Kimberly Kayser, Susan G. Groshen, Marc Chioda, Holger C. Thurm, Joseph Chen, Gerson Peltz et al. „Phase I trial of lorlatinib in patients with ALK-driven refractory or relapsed neuroblastoma: A New Approaches to Neuroblastoma Consortium study.“ Journal of Clinical Oncology 38, Nr. 15_suppl (20.05.2020): 10504. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.10504.
Der volle Inhalt der QuelleWidemann, B. C., E. Fox, P. C. Adamson, S. Baruchel, A. Kim, A. M. Ingle, J. Glade Bender, D. Stempak, F. M. Balis und S. M. Blaney. „Phase I study of sorafenib in children with refractory solid tumors: A Children's Oncology Group Phase I Consortium trial“. Journal of Clinical Oncology 27, Nr. 15_suppl (20.05.2009): 10012. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.10012.
Der volle Inhalt der QuelleHan, Lei, Andreja Kutnar, Jakub Sandak, Iztok Šušteršič und Dick Sandberg. „Adhesive- and Metal-Free Assembly Techniques for Prefabricated Multi-Layer Engineered Wood Products: A Review on Wooden Connectors“. Forests 14, Nr. 2 (05.02.2023): 311. http://dx.doi.org/10.3390/f14020311.
Der volle Inhalt der QuelleMosse, Yael P., Frank M. Balis, Megan S. Lim, Julie Laliberte, Stephan D. Voss, Elizabeth Fox, Rochelle Bagatell et al. „Efficacy of crizotinib in children with relapsed/refractory ALK-driven tumors including anaplastic large cell lymphoma and neuroblastoma: A Children's Oncology Group phase I consortium study.“ Journal of Clinical Oncology 30, Nr. 15_suppl (20.05.2012): 9500. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9500.
Der volle Inhalt der QuelleMorris, Michael J., Justine Yang Bruce, Leonard M. Reyno, Banmeet Anand, Alan Hartford, Kathy Jelaca-Maxwell, Jacqueline Lackey und Mario A. Eisenberger. „Phase I trial of ASG-5ME in metastatic castration-resistant prostate cancer (CRPC).“ Journal of Clinical Oncology 30, Nr. 15_suppl (20.05.2012): 4568. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.4568.
Der volle Inhalt der QuelleLim, Michael, Xiaobu Ye, Anna F. Piotrowski, Arati Suvas Desai, Manmeet Singh Ahluwalia, Tobias Walbert, Joy D. Fisher et al. „Updated phase I trial of anti-LAG-3 or anti-CD137 alone and in combination with anti-PD-1 in patients with recurrent GBM.“ Journal of Clinical Oncology 37, Nr. 15_suppl (20.05.2019): 2017. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.2017.
Der volle Inhalt der QuelleChumsri, Saranya, Sharmila Giri, Andrew Ness, David W. Hillman, Nadine Norton, Davitte Cogen, Edward Famularo et al. „Safety run-in phase of the multi-epitope HER2 peptide vaccine in combination with trastuzumab emtansine in HER2-positive breast cancer with residual disease after neoadjuvant chemotherapy.“ Journal of Clinical Oncology 42, Nr. 16_suppl (01.06.2024): 550. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.550.
Der volle Inhalt der QuelleMehra, Sameer, Annette M. Harte, Adeayo Sotayo, Zhongwei Guan und Conan O’Ceallaigh. „Experimental investigation on the effect of accelerated ageing conditions on the pull-out capacity of compressed wood and hardwood dowel type fasteners“. Holzforschung 76, Nr. 1 (01.01.2021): 89–98. http://dx.doi.org/10.1515/hf-2021-0097.
Der volle Inhalt der QuelleCotoras, Davor, Cristian Hurtado und Pabla Viedma. „Integrated Sulfate Reduction and Biosorption Process for the Treatment of Mine Drainages“. Solid State Phenomena 262 (August 2017): 582–86. http://dx.doi.org/10.4028/www.scientific.net/ssp.262.582.
Der volle Inhalt der QuelleHammoud, Obadah, Ivan Tarkhanov und Artyom Kosmarski. „An Architecture for Distributed Electronic Documents Storage in Decentralized Blockchain B2B Applications“. Computers 10, Nr. 11 (04.11.2021): 142. http://dx.doi.org/10.3390/computers10110142.
Der volle Inhalt der QuelleDeWire, Mariko, Christine Fuller, Olivia Campagne, Tong Lin, Haitao Pan, Tina Young-Pussaint, Patricia Baxter et al. „EPCT-17. A PHASE I AND SURGICAL STUDY OF RIBOCICLIB AND EVEROLIMUS IN CHILDREN WITH RECURRENT OR REFRACTORY MALIGNANT BRAIN TUMORS: PEDIATRIC BRAIN TUMOR CONSORTIUM INTERIM REPORT“. Neuro-Oncology 22, Supplement_3 (01.12.2020): iii307. http://dx.doi.org/10.1093/neuonc/noaa222.139.
Der volle Inhalt der QuelleLeary, Sarah, Julie R. Park, Joel M. Reid, Andrew T. Ralya, Sylvain Baruchel, Bing Wu, Ashish M. Ingle, Charlotte H. Ahern, Brenda Weigel und Susan Blaney. „A phase I trial and pharmacokinetic study of trebananib (AMG386) in children with recurrent or refractory solid tumors: A Children’s Oncology Group Phase 1 Consortium report.“ Journal of Clinical Oncology 31, Nr. 15_suppl (20.05.2013): 2538. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.2538.
Der volle Inhalt der QuelleMatthay, Katherine K., Jessica C. Tan, Judith G. Villablanca, Gregory A. Yanik, Janet Veatch, Benjamin Franc, Eilish Twomey et al. „Phase I Dose Escalation of Iodine-131–Metaiodobenzylguanidine With Myeloablative Chemotherapy and Autologous Stem-Cell Transplantation in Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Consortium Study“. Journal of Clinical Oncology 24, Nr. 3 (20.01.2006): 500–506. http://dx.doi.org/10.1200/jco.2005.03.6400.
Der volle Inhalt der QuelleVan Mater, David, Sridharan Gururangan, Sarah Leary, Oren Becher, Joanna Phillips, Jie Huang, Olivia Campagne et al. „EPCT-05. A PHASE I TRIAL OF THE CDK 4/6 INHIBITOR PALBOCICLIB IN PEDIATRIC PATIENTS WITH PROGRESSIVE OR REFRACTORY CNS TUMORS: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY“. Neuro-Oncology 22, Supplement_3 (01.12.2020): iii304. http://dx.doi.org/10.1093/neuonc/noaa222.129.
Der volle Inhalt der QuelleElhalis, Hosam, Xin Yi See, Raffael Osen, Xin Hui Chin und Yvonne Chow. „Significance of Fermentation in Plant-Based Meat Analogs: A Critical Review of Nutrition, and Safety-Related Aspects“. Foods 12, Nr. 17 (27.08.2023): 3222. http://dx.doi.org/10.3390/foods12173222.
Der volle Inhalt der QuelleArgumedo-Delira, Rosalba, Mario J. Gómez-Martínez und Brenda Joan Soto. „Gold Bioleaching from Printed Circuit Boards of Mobile Phones by Aspergillus niger in a Culture without Agitation and with Glucose as a Carbon Source“. Metals 9, Nr. 5 (07.05.2019): 521. http://dx.doi.org/10.3390/met9050521.
Der volle Inhalt der QuelleMora-Salguero, Daniela, Martha Josefina Vives Florez, Johanna Husserl Orjuela, Miguel Fernández-Niño und Andrés Fernando González Barrios. „Evaluation of the phenol degradation capacity of microalgae-bacteria consortia from the bay of Cartagena, Colombia“. TecnoLógicas 22, Nr. 44 (15.01.2019): 149–58. http://dx.doi.org/10.22430/22565337.1179.
Der volle Inhalt der QuelleCairo, Mitchell S., Erin Cooney, Mark Krailo, Richard Belanger, Sherrie L. Perkins, Rashid Fawwaz, Anne Angiolillo und Peter Adamson. „A Phase I Study of 90Y-Ibritumomab-Tiuxetan (90Y-It) in Children with Recurrent/Refractory CD20 Positive Lymphoma: A Cog Phase I Consortium Study.“ Blood 106, Nr. 11 (16.11.2005): 2448. http://dx.doi.org/10.1182/blood.v106.11.2448.2448.
Der volle Inhalt der QuelleAlSkaif, Tarek, Bart Holthuizen, Wouter Schram, Ioannis Lampropoulos und Wilfried van Sark. „A Blockchain-Based Configuration for Balancing the Electricity Grid with Distributed Assets“. World Electric Vehicle Journal 11, Nr. 4 (30.09.2020): 62. http://dx.doi.org/10.3390/wevj11040062.
Der volle Inhalt der QuelleVaravallo, Giuseppe, Giuseppe Caragnano, Fabrizio Bertone, Luca Vernetti-Prot und Olivier Terzo. „Traceability Platform Based on Green Blockchain: An Application Case Study in Dairy Supply Chain“. Sustainability 14, Nr. 6 (11.03.2022): 3321. http://dx.doi.org/10.3390/su14063321.
Der volle Inhalt der QuelleNetto, G., A. Armstrong, D. Wood, P. Creel, A. Partin, A. Jimeno, M. Rudek, D. George, R. Gurganus und M. A. Carducci. „Pharmacodynamic (PD) study of pre-prostatectomy rapamycin in men with advanced localized prostate cancer (PC): A DOD Prostate Cancer Clinical Trials Consortium Trial“. Journal of Clinical Oncology 27, Nr. 15_suppl (20.05.2009): 5001. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.5001.
Der volle Inhalt der QuelleWeingart, Jon, Stuart A. Grossman, Kathryn A. Carson, Joy D. Fisher, Shannon M. Delaney, Mark L. Rosenblum, Alessandro Olivi, Kevin Judy, Stephen B. Tatter und M. Eileen Dolan. „Phase I Trial of Polifeprosan 20 With Carmustine Implant Plus Continuous Infusion of Intravenous O6-Benzylguanine in Adults With Recurrent Malignant Glioma: New Approaches to Brain Tumor Therapy CNS Consortium Trial“. Journal of Clinical Oncology 25, Nr. 4 (01.02.2007): 399–404. http://dx.doi.org/10.1200/jco.2006.06.6290.
Der volle Inhalt der QuellePedrotti, Carine, Clarissa Franzoi, Rafael Nicolas Sandi, Daniel Santos Grohs und Joséli Schwambach. „Eucalyptus staigeriana essential oil can control downy mildew in grapevine“. Pesquisa Agropecuária Gaúcha 28, Nr. 1 (27.12.2021): 1–14. http://dx.doi.org/10.36812/pag.20222811-14.
Der volle Inhalt der QuelleDale, Michael J., und Carl Sanniti. „Litigation as an Instrument for Change in Juvenile Detention: A Case Study“. Crime & Delinquency 39, Nr. 1 (Januar 1993): 49–67. http://dx.doi.org/10.1177/0011128793039001004.
Der volle Inhalt der QuelleHoldhoff, Matthias, Stuart A. Grossman, Jeffrey G. Supko, Xiaobu Ye, Joy D. Fisher, Serena Desideri, Richard L. Wahl und David Schiff. „Sequential therapy with the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas: An Adult Brain Tumor Consortium phase I study (ABTC1101).“ Journal of Clinical Oncology 31, Nr. 15_suppl (20.05.2013): TPS2105. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.tps2105.
Der volle Inhalt der Quelle